Literature DB >> 16699053

Temporal artery biopsy for diagnosing giant cell arteritis: the longer, the better?

A Mahr1, M Saba, M Kambouchner, M Polivka, M Baudrimont, I Brochériou, J Coste, L Guillevin.   

Abstract

OBJECTIVE: To investigate the relation between temporal artery biopsy (TAB) length and diagnostic sensitivity for giant cell arteritis.
METHODS: Histological TAB reports generated from four hospital pathology departments were reviewed for demographics, histological findings, and formalin fixed TAB lengths. A biopsy was considered positive for giant cell arteritis if there was a mononuclear cell infiltrate predominating at the media-intima junction or in the media.
RESULTS: Among 1821 TAB reports reviewed, 287 (15.8%) were excluded because of missing data, sampling errors, or age < 50 years. Mean TAB length of the 1520 datasets finally analysed (67.2% women; mean (SD) age, 73.1 (10.0) years) was 1.33 (0.73) cm. Histological evidence of giant cell arteritis was found in 223 specimens (14.7%), among which 164 (73.5%) contained giant cells. Statistical analyses, including piecewise logistic regression, identified 0.5 cm as the TAB length change point for diagnostic sensitivity. Compared with TAB length of < 0.5 cm, the respective odds ratios for positive TAB without and with multinucleated giant cells in samples > or = 0.5 cm long were 5.7 (95% confidence interval, 1.4 to 23.6) and 4.0 (0.97 to 16.5).
CONCLUSIONS: A fixed TAB length of at least 0.5 cm could be sufficient to make a histological diagnosis of giant cell arteritis.

Entities:  

Mesh:

Year:  2006        PMID: 16699053      PMCID: PMC1798165          DOI: 10.1136/ard.2005.042770

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  13 in total

1.  Temporal artery biopsy: is there any value in examining biopsies at multiple levels?

Authors:  A Chakrabarty; A J Franks
Journal:  J Clin Pathol       Date:  2000-02       Impact factor: 3.411

2.  Shrinkage: fact or fiction?

Authors:  H V Danesh-Meyer; P J Savino; J R Bilyk; R C Eagle; R C Sergott
Journal:  Arch Ophthalmol       Date:  2001-08

Review 3.  Polymyalgia rheumatica and giant-cell arteritis.

Authors:  Carlo Salvarani; Fabrizio Cantini; Luigi Boiardi; Gene G Hunder
Journal:  N Engl J Med       Date:  2002-07-25       Impact factor: 91.245

4.  BMDP program for piecewise linear regression.

Authors:  T Nakamura
Journal:  Comput Methods Programs Biomed       Date:  1986-08       Impact factor: 5.428

Review 5.  Temporal artery biopsy.

Authors:  R B Kent; L Thomas
Journal:  Am Surg       Date:  1990-01       Impact factor: 0.688

Review 6.  Temporal arteritis: a clinical approach.

Authors:  A G Lee; P W Brazis
Journal:  J Am Geriatr Soc       Date:  1999-11       Impact factor: 5.562

7.  Skip lesions in temporal arteritis.

Authors:  R G Klein; R J Campbell; G G Hunder; J A Carney
Journal:  Mayo Clin Proc       Date:  1976-08       Impact factor: 7.616

Review 8.  Temporal artery biopsy in a dermatologic surgery practice.

Authors:  J G Albertini; M L Ramsey; V J Marks
Journal:  Dermatol Surg       Date:  1999-06       Impact factor: 3.398

Review 9.  Giant-cell arteritis and polymyalgia rheumatica.

Authors:  Cornelia M Weyand; Jörg J Goronzy
Journal:  Ann Intern Med       Date:  2003-09-16       Impact factor: 25.391

10.  Temporal arteritis. A clinicopathologic study.

Authors:  P J McDonnell; G W Moore; N R Miller; G M Hutchins; W R Green
Journal:  Ophthalmology       Date:  1986-04       Impact factor: 12.079

View more
  18 in total

Review 1.  Recent advances in diagnostic strategies for giant cell arteritis.

Authors:  Tanaz A Kermani; Kenneth J Warrington
Journal:  Curr Neurol Neurosci Rep       Date:  2012-04       Impact factor: 5.081

Review 2.  Giant cell arteritis: epidemiology, diagnosis, and management.

Authors:  Miguel A Gonzalez-Gay; Cristina Martinez-Dubois; Mario Agudo; Orlando Pompei; Ricardo Blanco; Javier Llorca
Journal:  Curr Rheumatol Rep       Date:  2010-12       Impact factor: 4.592

Review 3.  Polymyalgia rheumatica and giant cell arteritis in older patients: diagnosis and pharmacological management.

Authors:  Jean Schmidt; Kenneth J Warrington
Journal:  Drugs Aging       Date:  2011-08-01       Impact factor: 3.923

Review 4.  Giant Cell Arteritis: Practical Pearls and Updates.

Authors:  Swati Pradeep; Jonathan H Smith
Journal:  Curr Pain Headache Rep       Date:  2018-01-17

5.  Morphological features of temporal arteritis.

Authors:  William C Roberts; Saleha Zafar; Jo Mi Ko
Journal:  Proc (Bayl Univ Med Cent)       Date:  2013-04

6.  Clinical and technical determinants of positive temporal artery biopsy: a retrospective cohort study.

Authors:  Fatima Alnaimat; Ahmad T Mansour; Hamza Alduraidi; Soud Al-Qasem; Mohammad Hindi; Tala Rawashdeh; Eman Hassan; Sahar Almustafa; Refat Hanbali; Osama Ababneh
Journal:  Rheumatol Int       Date:  2021-10-18       Impact factor: 2.631

Review 7.  Neuro-ophthalmic complications in giant cell arteritis.

Authors:  Frances A Borg; Victoria L J Salter; Bhaskar Dasgupta
Journal:  Curr Allergy Asthma Rep       Date:  2008-07       Impact factor: 4.806

8.  Temporal artery biopsy for giant cell arteritis: retrospective audit.

Authors:  Habiba Saedon; Mahmud Saedon; Steve Goodyear; Trifonas Papettas; Colette Marshall
Journal:  JRSM Short Rep       Date:  2012-10-22

9.  A Stab in the Dark: A Case Report of an Atypical Presentation of Giant Cell Arteritis (GCA).

Authors:  Beth McCausland; David Desai; David Havard; Yasmin Kaur; Asalet Yener; Emma Bradley; Harnish P Patel
Journal:  Geriatrics (Basel)       Date:  2018-06-29

10.  Multivariable prediction model for suspected giant cell arteritis: development and validation.

Authors:  Edsel B Ing; Gabriela Lahaie Luna; Andrew Toren; Royce Ing; John J Chen; Nitika Arora; Nurhan Torun; Otana A Jakpor; J Alexander Fraser; Felix J Tyndel; Arun Ne Sundaram; Xinyang Liu; Cindy Ty Lam; Vivek Patel; Ezekiel Weis; David Jordan; Steven Gilberg; Christian Pagnoux; Martin Ten Hove
Journal:  Clin Ophthalmol       Date:  2017-11-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.